芬太尼关税
Search documents
关税战下的美国:关税收入、实际税率与贸易格局演变
Yuekai Securities· 2025-10-12 06:54
Revenue and Tax Rate Insights - U.S. tariff revenue surged to $144.4 billion in the first eight months of 2025, 2.8 times higher than the same period last year, making it the fourth largest source of federal revenue at 4.0%[12] - The average tariff rate increased from 2.2% in January to 8.9% in June 2025, reflecting a significant rise driven by higher tariff rates[16] Trade Partner Analysis - The actual average tariff rate on imports from China reached 37.4% in June 2025, up 26.5 percentage points from January, with a peak of 45.6% in May[27] - U.S. imports from China fell by 18.9% and exports by 20.2% in the first seven months of 2025, indicating a significant decline in trade volume[28] Trade Dynamics - U.S. imports grew by 10.7% and exports by 4.8% year-on-year in the first seven months of 2025, while the trade deficit expanded by 21.3%[27] - The U.S. reliance on Chinese imports decreased, with imports from China constituting 9.4% of total U.S. imports, down 3.4 percentage points year-on-year[5] Product-Specific Tariff Changes - Tariff rates on labor-intensive goods, such as toys and shoes, increased significantly, with rates rising by 24.2 and 13.1 percentage points respectively[37] - The "232 tariffs" on steel and aluminum products saw rates increase from 25% to 50%, leading to substantial hikes in actual tariff rates for these categories[38]
特朗普对部分木制家具加征关税,进一步增加美国人住房成本
Sou Hu Cai Jing· 2025-09-30 03:36
Core Points - The Trump administration continues to utilize import tariffs to revitalize U.S. manufacturing and strengthen national security [1][4] - New tariffs include a 10% tax on imported softwood lumber and a 25% tax on imported cabinets and wood products, effective from October 14, with some rates increasing on January 1 [1] - The increase in tariffs is expected to raise costs in the residential construction and renovation sectors, exacerbating housing affordability issues for average Americans [1] - Approximately 30% of the softwood used in the U.S. comes from Canada, which faces a 14.5% countervailing and anti-dumping duty [1] Industry Insights - The new tariffs are part of a broader strategy to restructure domestic supply chains, although domestic lumber production may not meet the immediate demands of builders [4] - There is a noted generational gap in interest towards manufacturing jobs, with younger individuals preferring careers in fields like social media and fashion design [4] - The latest tariff measures stem from an investigation initiated by the U.S. Department of Commerce under Section 232 of the Trade Expansion Act, which allows for tariffs based on national security concerns [4][5] Legislative Context - The U.S. Department of Commerce has also launched new investigations into imports of robots, industrial machinery, and medical devices under the same legal framework [5] - The International Emergency Economic Powers Act (IEEPA) allows the President to impose tariffs without stringent requirements to prove national security concerns, which has been a focal point in recent tariff implementations [5] - The legality of the White House's invocation of IEEPA is set to be debated in the Supreme Court on November 5 [5]
定了!美国最高法院将在11月开审,努力“迅速解决”特朗普关税案
Di Yi Cai Jing· 2025-09-10 07:33
Core Points - The U.S. Supreme Court is set to hear the "V.O.S. Selections v. Trump" case in the first week of November, indicating a swift resolution to the matter [1][3] - The case arises after the U.S. Court of Appeals ruled that most tariffs imposed by the Trump administration were illegal, leading the White House to request expedited review [1][4] - If the Supreme Court rules against the tariffs, the average effective tariff rate of 16.3% could be reduced by at least half, potentially resulting in the refund of hundreds of billions of dollars in tariffs [1][5] Legal Context - The Trump administration's tariffs are claimed to be authorized under the International Emergency Economic Powers Act (IEEPA), which does not explicitly grant the power to impose tariffs [4] - The U.S. Court of Appeals ruled 7-4 that the IEEPA does not authorize such broad tariffs, emphasizing that the Constitution grants Congress the power to set tariffs, not the President [4] Financial Implications - U.S. Treasury Secretary indicated that if the Supreme Court deems the tariffs illegal, the government may have to refund about half of the tariffs collected, which would be a significant financial burden [5] - As of August 12, the U.S. had collected $142 billion in tariff revenue for the fiscal year [5] Case Developments - The Court of Appeals upheld parts of the lower court's ruling but sent back the issue of a nationwide permanent injunction for further review, ensuring judicial authority is not overstepped [5] - The case reflects the ongoing tension between executive power and legislative authority regarding tariff imposition [4][5] Stakeholder Reactions - Legal representatives for companies affected by the tariffs are advocating for the protection of small businesses and adherence to the rule of law in light of what they describe as excessive tariff actions [6]
“对等关税”被裁定违法,特朗普称将上诉至美最高法院
Huan Qiu Shi Bao· 2025-08-31 22:49
Core Points - The U.S. government has been ruled illegal in its use of the International Emergency Economic Powers Act to impose tariffs, marking a significant setback for the aggressive trade policies of the Trump administration [1][3] - The ruling raises questions about the validity of previous trade agreements made with the U.S. [1][5] - The ruling was upheld by the Federal Circuit Court, which stated that the power to impose tariffs is a core authority of Congress, not the President [3][5] Summary by Sections Legal Ruling - The Federal Circuit Court maintained the previous ruling that the Trump administration's tariffs imposed under the International Emergency Economic Powers Act were illegal, with a vote of 7 to 4 [3] - The court emphasized that while the Act allows the President to take certain economic measures in emergencies, it does not grant the authority to impose tariffs through executive orders [3] Economic Impact - The ruling could have direct implications for the U.S. economy and may trigger reactions in global markets, as trade partners reassess the legal standing of U.S. tariffs [5] - The Trump administration collected approximately $107 billion in tariffs from February to July, a significant portion of which was based on the now-ruled illegal measures [4] Ongoing Trade Negotiations - The U.S. is still engaged in trade negotiations with multiple countries, including the UK, Vietnam, and the EU, but the legal uncertainty surrounding tariffs may complicate these discussions [6][7] - Japan's trade representative canceled a trip to the U.S. due to dissatisfaction with proposed U.S. tariffs, indicating potential friction in ongoing negotiations [7]
X @外汇交易员
外汇交易员· 2025-07-28 02:41
Trade Negotiation Outlook - Trade negotiations between China and the US in Stockholm are expected to result in a three-month extension of the tariff truce [1] - Both countries are expected to commit to refrain from imposing additional tariffs or escalating the trade war [1] Key Issues - The US will likely express concerns regarding China's excess industrial capacity [1] - China is expected to pressure the US regarding fentanyl tariffs [1]
美对中加征的“芬太尼关税”仍未取消,国家禁毒办回应
news flash· 2025-06-19 08:45
Core Viewpoint - The U.S. has not lifted the so-called "fentanyl tariffs" imposed on Chinese imports, which is viewed as a bullying tactic that undermines trust and dialogue in drug control efforts between the two countries [1] Group 1: U.S.-China Relations - The Chinese National Narcotics Control Commission criticized the U.S. for its actions, stating that it severely damages the foundation for cooperation in drug control [1] - China is recognized as one of the countries with the strictest and most comprehensive drug control policies in the world [1] Group 2: International Cooperation - China actively engages in international cooperation on drug control and has offered humanitarian assistance to help the U.S. address its fentanyl crisis, with visible results [1] - The Chinese government urges the U.S. to reflect seriously and adopt a responsible approach to reduce drug demand at the source, rather than shifting blame [1]
特朗普关税遭遇司法滑铁卢:美法院裁定特朗普不拥有无限征税权
Di Yi Cai Jing· 2025-05-29 07:15
Core Viewpoint - The U.S. International Trade Court (CIT) ruled that the International Emergency Economic Powers Act (IEEPA) does not grant the President unlimited authority to impose tariffs, leading to the annulment of related tariff measures [1][7]. Group 1: Court Ruling Details - The CIT combined two cases, one initiated by the Liberty Justice Center on behalf of five small businesses challenging the "reciprocal tariffs" and another by the Oregon Attorney General representing twelve states against global tariffs, retaliatory tariffs, and fentanyl tariffs [3]. - The court confirmed that the IEEPA does not explicitly authorize the President to impose unlimited tariffs, which have significant economic and political implications [4][5]. - The ruling stated that the tariffs imposed by the Trump administration exceeded the authority granted by the IEEPA and violated constitutional principles [6][7]. Group 2: Implications for Trade Policy - The ruling could represent a significant policy shift, particularly benefiting small and medium-sized enterprises that struggle to absorb the costs of tariffs [6]. - The decision emphasizes that trade decisions should not be made unilaterally by the President without Congressional authorization, reaffirming the importance of legislative oversight [4][5]. - The CIT's ruling applies nationwide, affecting all importers, but does not address tariffs authorized under other laws, such as those related to steel and aluminum [7].
对等关税被美国法院叫停,对华加征关税将终止?大概率还是加30%
Sou Hu Cai Jing· 2025-05-29 05:58
Group 1 - The recent ruling by the U.S. International Trade Court has blocked the "reciprocal tariffs" imposed by the Trump administration, indicating a significant check on the government's tariff policies [1][3]. - The initial round of tariffs against China, initiated in 2018, has established a legal framework that is unlikely to change in the short term, with a focus on the newly introduced tariffs this year [3][5]. - The "Fentanyl Tariff," which imposes a 20% tariff on Chinese goods, remains unaffected by the court's ruling, while the 10% "reciprocal tariff" is currently frozen but not entirely canceled [5][8]. Group 2 - The Trump administration has initiated an appeal against the court's decision, which may eventually reach the Supreme Court, where a conservative majority could potentially overturn the lower court's ruling [5][6]. - Even if the "reciprocal tariff" is deemed illegal, the Trump administration may find alternative justifications to impose tariffs, as demonstrated by the strategic use of the "Fentanyl Tariff" [8]. - The ongoing trade tensions necessitate a robust response strategy, including utilizing WTO dispute resolution mechanisms and enhancing domestic supply-side reforms to stabilize the economy [10].
一刻也不消停?美国又掀起一股风浪,想要全球封杀芯片,中方决不答应
Sou Hu Cai Jing· 2025-05-20 16:02
Group 1 - The core point of the article is the recent adjustment of tariffs between China and the United States, where both countries have agreed to cancel 91% of additional tariffs and suspend 24% of reciprocal tariffs, marking a temporary easing of trade tensions [1][3] - Following the tariff adjustments, there has been a surge in demand from American buyers for Chinese goods, with many U.S. companies pre-loading containers in anticipation of the changes [3][5] - The logistics company ITS Logistics predicts a 20% increase in shipping costs from China to the U.S. West Coast in the coming weeks, indicating a critical period for inventory accumulation for shippers and carriers [3][5] Group 2 - Despite the short-term benefits, U.S. businesses, especially small enterprises, express concerns about the potential policy shifts after the 90-day period, as they still face a 30% tariff burden [5][6] - The ongoing fentanyl tariff issue remains contentious, with the U.S. imposing additional tariffs on China under the pretext of fentanyl control, which China disputes [6][8] - The future trajectory of U.S.-China trade relations hinges on negotiations regarding the suspended tariffs and the fentanyl tariffs, emphasizing the need for constructive dialogue to resolve underlying tensions [8][9]
外交部称“芬太尼关税”损中美合作 超九成网友批美“霸凌成瘾”
Yang Zi Wan Bao Wang· 2025-05-13 10:42
Core Points - The Chinese Foreign Ministry criticized the U.S. for imposing a "fentanyl tariff," claiming it undermines dialogue and cooperation in drug control between the two countries and harms China's interests [1] - A CGTN poll indicated that 91.8% of respondents view the U.S. action as political manipulation and tariff bullying, aimed at covering up its own failures in drug control [1] - The poll revealed that 91% of respondents believe drug abuse is a major threat to American lives, and 94.8% see drug proliferation as a chronic issue in U.S. society [1] Summary by Sections U.S. Drug Problem - Fentanyl is identified as a U.S. issue rather than a Chinese one, with the responsibility lying within the U.S. itself [1] - The CDC reports that among approximately 280 million Americans aged 12 and older, 1 in 12 is involved in drug use, with around 60% of global drug production entering the U.S. [1] Public Sentiment - Concerns about the rising trend of drug use among American youth are prevalent, with respondents expressing disbelief that the country with the highest drug prevalence is also the largest economy [1] - 92.8% of respondents believe the current situation reflects a significant failure of the U.S. government in regulating drug abuse [1] Government Response - The U.S. government has been criticized for its lack of action in controlling prescription drugs and educating the public about drug dangers, while also being accused of promoting drug legalization for economic interests [1] - 90.8% of respondents think the U.S. is attempting to shift the blame for its drug abuse issues onto other countries, which undermines international drug control cooperation [1]